Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v12-FR
Language French French
Date Updated 2019-02-07 2019-02-05
Drug Identification Number 02436612 02436612
Brand name NAT-RIZATRIPTAN ODT NAT-RIZATRIPTAN ODT
Common or Proper name Rizatriptan Rizatriptan
Company Name NATCO PHARMA (CANADA) INC NATCO PHARMA (CANADA) INC
Ingredients RIZATRIPTAN RIZATRIPTAN
Strength(s) 10MG 10MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 6 6
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2019-01-01 2019-01-01
Actual start date
Estimated end date 2019-02-06 2019-02-06
Actual end date 2019-02-06 2019-02-06
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments